Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 187   

Articles published

AZN 4,338.50 -6.00 (-0.14%)
price chart
Is AstraZeneca plc The #1 Healthcare Play Today?
AstraZeneca It's been an interesting year for investors in AstraZeneca (LSE: AZN) (NYSE: AZN.US). Indeed, it has been the subject of several unsuccessful takeover attempts by Pfizer and has seen its share price rise by 20% over the course of 2014 ...
AstraZeneca Raises 2014 Guidance  Bidness Etc
AstraZeneca to Buy Rights to Almirall Respiratory Drugs  Wall Street Journal
Related articles »  
AstraZeneca plc Rating Reiterated by Berenberg Bank (AZN)
AstraZeneca plc (ADR) logo Berenberg Bank reissued their hold rating on shares of AstraZeneca plc (NYSE:AZN) in a research report released on Thursday morning.
AstraZeneca plc (AZN) Posts Quarterly Earnings, Beats Estimates By $0.21 EPS  Watch List News (press release)
AstraZeneca plc's "Hold" Rating Reaffirmed at Berenberg Bank (AZN)  Intercooler
Related articles »  
3 Things That Say AstraZeneca plc Is A Buy
AstraZeneca (LSE: AZN) (NYSE: AZN.US) is an interesting proposition. The FTSE 100′s second-biggest pharmaceuticals firm was looking a bit lost a few years ago, and its strategy for coping with the expiry of some key patents and increasing competition ...
Related articles »  
Neil Woodford's Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco ...
AstraZeneca (LSE: AZN), BT Group (LSE: BT-A), Rolls-Royce (LSE: RR) and Imperial Tobacco (LSE: IMT) account for about 23% of Neil Woodford's new equity portfolio.
Jefferies Group Reiterates Hold Rating for AstraZeneca plc (AZN)
Jefferies Group reiterated their hold rating on shares of AstraZeneca plc (LON:AZN) in a research report released on Thursday morning.
AstraZeneca plc Receives �Hold� Rating from Berenberg Bank (AZN)  Ticker Report
AstraZeneca plc Receives Average Rating of �Hold� from Brokerages (LON:AZN)  Intercooler
Related articles »  
Is It Time To Sell AstraZeneca plc?
AstraZeneca Most potential and actual AstraZeneca (LSE: AZN) (NYSE: AZN.US) investors will know that American drugs giant Pfizer tried to take the firm over recently.
AstraZeneca plc Given �Neutral� Rating at Credit Suisse (AZN)  Ticker Report
Is Pfizer Inc. (NYSE:PFE) A Buy?  WallStreetPR
Related articles »  
Eyes Down For AstraZeneca plc Results
astrazeneca We haven't had any results from AstraZeneca (LSE: AZN) (NYSE: AZN.US) since the failed takeover bid to see how things are going, but there will be many eyes, including Pfizer's no doubt, focused on first-half figures when we get them on ...
Related articles »  
Is Roche Eyeing Up A Bid For AstraZeneca plc?
AstraZeneca's (LSE: AZN) (NYSE: AZN.US) decision to turn down Pfizer's �55 per share takeover offer split opinions.
AstraZeneca plc Price Target Increased to GBX 4000 by Analysts at Deutsche ...
AstraZeneca plc logo Research analysts at Deutsche Bank boosted their target price on shares of AstraZeneca plc (LON:AZN) from GBX 3,950 ($67.07) to GBX 4,000 ($67.92) in a report released on Friday.
Should You Buy GlaxoSmithKline plc Or AstraZeneca plc?
GlaxoSmithKline It's been a disappointing year thus far for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), with shares in the pharmaceutical company being down 6%.
GlaxoSmithKline plc trims 2014 forecast  ValueWalk
Related articles »